Learn more about COVID-19 in Saskatchewan. Daily case numbers and information for businesses and workers.

The Re-Open Saskatchewan plan was released on April 23rd.

Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

COVID-19 Convalescent Plasma Collection

Canadian Blood Services and Canadian Plasma Resources are working with Health Canada and the international research community to determine if convalescent plasma could be used as an effective treatment for COVID-19.

When someone contracts a virus, their body develops antibodies against it. The antibodies remain present in their plasma to shield them from possible future infection. These antibodies could be the key ingredient for a treatment to help others with the same virus. Global efforts are currently underway to study COVID-19 convalescent plasma as a potential treatment.

Plasma is the straw-coloured liquid portion of blood. The protein-rich fraction of plasma is used to manufacture therapies.

COVID-19 convalescent plasma is collected through the plasma donation process from a person who has recovered from COVID-19.

To participate, convalescent plasma donors must be:

  • Younger than 67 years old;
  • Previously confirmed positive for COVID-19 by a laboratory test; and
  • Fully recovered from the virus and symptom free for at least 28 days.

Canadian Blood Services

Canadian Blood Services (CBS) is part of a national clinical trial (CONCOR) to test the safety and effectiveness of COVID-19 convalescent plasma as a possible treatment to help patients with the virus. This includes supplying convalescent plasma to physicians caring for patients with the virus in the context of the clinical trial.

Convalescent plasma donors must live within reasonable driving distance from a Canadian Blood Services donor centre. CBS has confirmed that COVID-19 convalescent plasma can be collected at all fixed donor centres across Canada. Saskatchewan residents can participate and donate their plasma in both Regina and Saskatoon locations.

Patients can register their intention to be a donor at the Canadian Blood Services website.

Canadian Plasma Resources

Canadian Plasma Resources (CPR) is part of the supply chain to collect convalescent plasma as a possible treatment for COVID-19. CPR will collect and supply plasma for BioTest Ag and Emergent BioSolutions Inc. to be used in clinical trials in the U.S.

Plasma will be collected from compensated donors in Saskatoon.

Patients can obtain more information on the Canadian Plasma Resources website.

We need your feedback to improve saskatchewan.ca. Help us improve